| Title: |
Excessive Daytime Sleepiness in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure: Data From the European Sleep Apnea Database |
| Authors: |
Bonsignore M. R.; Pepin J. L.; Cibella F.; Barbera C. D.; Marrone O.; Verbraecken J.; Saaresranta T.; Basoglu O. K.; Trakada G.; Bouloukaki I.; McNicholas W. T.; Bailly S.; Pataka A.; Kvamme J. A.; Hein H.; Mihaicuta S.; Grote L.; Fanfulla F. |
| Contributors: |
Bonsignore M.R.; Pepin J.L.; Cibella F.; Barbera C.D.; Marrone O.; Verbraecken J.; Saaresranta T.; Basoglu O.K.; Trakada G.; Bouloukaki I.; McNicholas W.T.; Bailly S.; Pataka A.; Kvamme J.A.; Hein H.; Mihaicuta S.; Grote L.; Fanfulla F. |
| Publisher Information: |
Frontiers Media S.A. |
| Publication Year: |
2021 |
| Collection: |
IRIS Università degli Studi di Palermo |
| Subject Terms: |
CPAP adherence; Epworth Sleepiness Scale; follow-up; residual sleepine; sleep duration; sleep latency; Settore MED/10 - Malattie Dell'Apparato Respiratorio |
| Description: |
Excessive daytime sleepiness (EDS) is a symptom of obstructive sleep apnea (OSA) that resolves under treatment with continuous positive airway pressure (CPAP). In some patients, sleepiness persists despite CPAP treatment. We retrospectively analyzed data on subjective residual EDS, assessed as an Epworth Sleepiness Scale score (ESS) >10, in patients from the European Sleep Apnea Database (n = 4,853, mean age ± SD 54.8 ± 11.8 years, 26.1% females), at baseline and at the first visit (median follow-up: 5 months, interquartile range 3–13). An ESS > 10 occurred in 56% of patients at baseline and in 28.2% of patients at follow-up. Residual EDS was analyzed in 2,190 patients (age: 55.1 ± 12.0 years, 26.1% females) with sleep monitoring data (median follow-up: 3 months, interquartile range 1–15). Sleep studies during CPAP use were obtained in 58% of these patients; EDS was reported by 47.2% of patients at baseline and by 30.3% at follow-up. Residual OSA, defined as an apnea–hypopnea index >10/h, and insufficient CPAP adherence, defined as nightly use 10 at the first follow-up visit was associated directly with ESS at baseline and inversely with duration of follow-up, and CPAP use (R2 of the model: 0.417). EDS showed heterogeneity in different European countries both at baseline and at the first follow-up visit, suggesting modulation by cultural and lifestyle factors. In conclusion, residual EDS in CPAP-treated OSA occurred in approximately one in four patients at follow-up; its prevalence was highest (40%) in the first 3 months of treatment and subsequently decreased. The finding of residual EDS in ... |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| Relation: |
info:eu-repo/semantics/altIdentifier/pmid/34434158; info:eu-repo/semantics/altIdentifier/wos/WOS:000684985700002; volume:12; numberofpages:11; journal:FRONTIERS IN NEUROLOGY; https://hdl.handle.net/10447/522203 |
| DOI: |
10.3389/fneur.2021.690008 |
| Availability: |
https://hdl.handle.net/10447/522203; https://doi.org/10.3389/fneur.2021.690008 |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edsbas.C6D14546 |
| Database: |
BASE |